Clinical Trial Update: Gene Therapy for Painful Diabetic Neuropathy [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports completed Phase 1/Phase 2 results for VM202 gene therapy in patients with painful diabetic peripheral neuropathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Painful Diabetic Peripheral Neuropathy

Drugs mentioned

• VM202 (hepatocyte growth factor gene therapy)

Snippet

Sponsor: Helixmith Co., Ltd. | Conditions: Painful Diabetic Peripheral Neuropathy | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2025-06-15